Children’s Oncology Group (COG) Trials for Retinoblastoma

Dan S. Gombos; Anna T. Meadows; Murali Chintagumpala; Ira J. Dunkel; Debra Friedman; Julie Ann Stoner; Rima Fuad Jubran; Judith Grob Villablanca

doi:10.1007/978-3-030-11123-6_25

Children’s Oncology Group (COG) Trials for Retinoblastoma

Dan S. Gombos, Anna T. Meadows, Murali Chintagumpala, Ira J. Dunkel, Debra Friedman, Julie Ann Stoner, Rima Fuad Jubran, Judith Grob Villablanca

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The past decade has witnessed significant multidisciplinary, prospective, clinical, and biologic studies of retinoblastoma. The Children’s Oncology Group (COG) has successfully opened five clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional feasibility study of intra-arterial chemotherapy given in the ophthalmic artery of children with retinoblastoma has been initiated.

Original language	English (US)
Title of host publication	Clinical Ophthalmic Oncology
Subtitle of host publication	Retinoblastoma
Publisher	Springer International Publishing
Pages	275-284
Number of pages	10
ISBN (Electronic)	9783030111236
ISBN (Print)	9783030111229
DOIs	https://doi.org/10.1007/978-3-030-11123-6_25
State	Published - Jan 1 2019

Keywords

Chemotherapy
Children’s Oncology Group
COG
Trials

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-11123-6_25

Cite this

@inbook{31a692c199ad491e95f0383f71305a4c,

title = "Children{\textquoteright}s Oncology Group (COG) Trials for Retinoblastoma",

abstract = "The past decade has witnessed significant multidisciplinary, prospective, clinical, and biologic studies of retinoblastoma. The Children{\textquoteright}s Oncology Group (COG) has successfully opened five clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional feasibility study of intra-arterial chemotherapy given in the ophthalmic artery of children with retinoblastoma has been initiated.",

keywords = "Chemotherapy, Children{\textquoteright}s Oncology Group, COG, Trials",

author = "Gombos, \{Dan S.\} and Meadows, \{Anna T.\} and Murali Chintagumpala and Dunkel, \{Ira J.\} and Debra Friedman and \{Ann Stoner\}, Julie and \{Fuad Jubran\}, Rima and \{Grob Villablanca\}, Judith",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019. All rights are reserved.",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-11123-6\_25",

language = "English (US)",

isbn = "9783030111229",

pages = "275--284",

booktitle = "Clinical Ophthalmic Oncology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Children’s Oncology Group (COG) Trials for Retinoblastoma

AU - Gombos, Dan S.

AU - Meadows, Anna T.

AU - Chintagumpala, Murali

AU - Dunkel, Ira J.

AU - Friedman, Debra

AU - Ann Stoner, Julie

AU - Fuad Jubran, Rima

AU - Grob Villablanca, Judith

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2019. All rights are reserved.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The past decade has witnessed significant multidisciplinary, prospective, clinical, and biologic studies of retinoblastoma. The Children’s Oncology Group (COG) has successfully opened five clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional feasibility study of intra-arterial chemotherapy given in the ophthalmic artery of children with retinoblastoma has been initiated.

AB - The past decade has witnessed significant multidisciplinary, prospective, clinical, and biologic studies of retinoblastoma. The Children’s Oncology Group (COG) has successfully opened five clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional feasibility study of intra-arterial chemotherapy given in the ophthalmic artery of children with retinoblastoma has been initiated.

KW - Chemotherapy

KW - Children’s Oncology Group

KW - COG

KW - Trials

UR - https://www.scopus.com/pages/publications/105011451759

UR - https://www.scopus.com/inward/citedby.url?scp=105011451759&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-11123-6_25

DO - 10.1007/978-3-030-11123-6_25

M3 - Chapter

AN - SCOPUS:105011451759

SN - 9783030111229

SP - 275

EP - 284

BT - Clinical Ophthalmic Oncology

PB - Springer International Publishing

ER -

Children’s Oncology Group (COG) Trials for Retinoblastoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this